This study explored the expression, occurrence, and treatment outcomes of comorbid body dysmorphic disorder (BDD) in 107 youth (7-17 years) seeking treatment for primary obsessive-compulsive disorder (OCD). In the overall sample, appearance anxiety (AA) was positively associated with OCD-related impairment, severity, symptom frequency, comorbid symptoms, and maladaptive emotion regulation. Comorbid BDD occurred in 9.35% of youth, equally affected males and females, and was associated with older age. AA negligibly reduced following treatment. Compared to those without (a) comorbid BDD and (b) without any comorbidity, youth with comorbid BDD reported greater social impairment and reduced global functioning but did not differ on the occurrence of comorbid anxiety and mood disorders. OCD response or remission rates did not differ. In youth with comorbid BDD, AA did not significantly reduce following treatment. Results suggest a more severe expression accompanies comorbid BDD in youth with OCD, with BDD persisting following OCD treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272246 | PMC |
| http://dx.doi.org/10.1007/s10578-022-01314-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the Prevalence and Etiological Factors of Body Dysmorphic Disorder in Cosmetic Surgery Populations: Implications for Enhanced Clinical Assessment.
Aesthetic Plast Surg
December 2024
Department of Plastic and Reconstructive Surgery, Peking University Shenzhen Hospital, 1120 Lianghua Road, Shenzhen, 518036, Guangdong, China.
Background: The prevalence of body dysmorphic disorder (BDD) varies across different clinical settings, with evidence indicating its notable presence not only in psychiatric environments but also in dermatology and plastic surgery. This article aims to investigate the etiological factors associated with the elevated incidence of BDD in plastic surgery outpatient settings, with the ultimate objective of enhancing the assessment process for potential cosmetic procedure candidates.
Methods: We recruited 531 patients seeking consultations or surgeries at the Department of Plastic Surgery, Peking University Shenzhen Hospital, from October 2022 to February 2024.
Article Synopsis
- Body dysmorphic disorder (BDD) is a serious and often overlooked mental health condition that requires improved treatment options due to its severe associated issues.
- The review highlights the main treatment method, cognitive-behavioral therapy (CBT), and discusses new developments like digital interventions and the need for targeted treatments for adolescents.
- It also identifies a gap in research for underserved communities and emphasizes the need for culturally appropriate care, concluding with suggestions for future research and treatment advancements.
Metacognitive Therapy for Body Dysmorphic Disorder: A Consecutive Case Series.
J Cogn Psychother
September 2024
Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway.
Research suggests that metacognitions could be important in explaining symptoms of body dysmorphic disorder (BDD), but the effect of metacognitive therapy (MCT) on BDD is unknown. The aim of this consecutive case series was to explore MCT for BDD, delivered individually within a public mental health setting. Treatment was based on MCT manuals for obsessive-compulsive disorder and generalized anxiety disorder.
View Article and Find Full Text PDFAverage Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder.
Subst Use Addctn J
October 2024
Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA), Division of Epidemiology, Department of Medicine, School of Medicine, University of Utah, Salt Lake City, UT, USA.
Background: High-dose (≥24 mg) buprenorphine daily doses (BDD) may be important in treating patients with opioid use disorder (OUD) to improve retention and prevent overdose, particularly in the context of increased illicit fentanyl use. This study sought to: (1) identify trajectories for average BDD among patients initiating buprenorphine treatment for OUD and (2) assess patient characteristics associated with these identified trajectories.
Methods: Buprenorphine treatment episodes among patients in the US Veterans Healthcare Administration (VHA) from federal fiscal years 2006 to 2020 were identified.
Prevalence of body dysmorphic disorder, its clinical characteristics and psychiatric comorbidities in patients admitted to a plastic surgery outpatient clinic.
Nord J Psychiatry
August 2024
Department of Psychiatry, Konya Numune Hospital, Konya, Turkey.
Article Synopsis
- The study investigated the prevalence, clinical features, and comorbidity of body dysmorphic disorder (BDD) among patients seeking plastic and reconstructive surgery, finding a BDD prevalence of 4.7% overall and 8.6% specifically in cosmetic procedure seekers.
- Researchers assessed participants using various psychological scales, discovering that those with BDD had significantly higher anxiety and depression scores compared to controls.
- The findings highlight the critical need to identify individuals with BDD before they undergo surgery to prevent unnecessary procedures and address their mental health issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!